Randomized Trial of Longer-Term Therapy for Symptoms Attributed to Lyme Disease | Zendy

Anneleen Berende | Zendy; Hadewych J. M. ter Hofstede | Zendy; Fidel J. Vos | Zendy; Henriët van Middendorp | Zendy; Michiel L. Vogelaar | Zendy; Mirjam Tromp | Zendy; F.H.J. van den Hoogen | Zendy; A. Rogier T. Donders | Zendy; Andrea W.M. Evers | Zendy; Bart Jan Kullberg | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Randomized Trial of Longer-Term Therapy for Symptoms Attributed to Lyme Disease

Author(s) -

Anneleen Berende,

Hadewych J. M. ter Hofstede,

Fidel J. Vos,

Henriët van Middendorp,

Michiel L. Vogelaar,

Mirjam Tromp,

F.H.J. van den Hoogen,

A. Rogier T. Donders,

Andrea W.M. Evers,

Bart Jan Kullberg

Publication year - 2016

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1505425

Subject(s) - medicine , lyme disease , doxycycline , randomized controlled trial , placebo , borrelia burgdorferi , randomization , ceftriaxone , clarithromycin , surgery , antibiotics , immunology , pathology , microbiology and biotechnology , biology , helicobacter pylori , alternative medicine , antibody

The treatment of persistent symptoms attributed to Lyme disease remains controversial. We assessed whether longer-term antibiotic treatment of persistent symptoms attributed to Lyme disease leads to better outcomes than does shorter-term treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research